Diagnostic utility of alarm features for colorectal cancer: Systematic review and meta-analysis

Gut

Volumn 57, Issue 11, 2008, Pages 1545-1552

  Ford, Alex C ^a   Veldhuyzen Van Zanten, S J O ^b   Rodgers, C C ^c   Talley, N J ^d   Vakil, N B ^e   Moayyedi, P ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL MASS; ARTICLE; CINAHL; CLINICAL TRIAL; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; EMBASE; GASTROINTESTINAL SYMPTOM; HUMAN; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PUBLICATION; RECTUM HEMORRHAGE; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; SYMPTOM; SYSTEMATIC REVIEW;

ABDOMINAL NEOPLASMS; ADULT; ANEMIA; COLORECTAL NEOPLASMS; DEFECATION; DIARRHEA; EUROPE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; NORTH AMERICA; RECTUM; SENSITIVITY AND SPECIFICITY; WEIGHT LOSS;

EID: 54349119864     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2008.159723     Document Type: Article

References (37)

1. American Cancer Society. Cancer facts & figures 2007. http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf (accessed 13 Aug 2008).
2. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-92.
3. Majumdar SR, Fletcher RH, Evans AT. How does colorectal cancer present? Symptoms, duration, and clues to location. Am J Gastroenterol 1999;94:3039-45.
4. Keddie N, Hargreaves A. Symptoms of carcinoma of the colon and rectum. Lancet 1968;292:749-50.
5. Agreus L, Svardsudd K, Talley NJ, et al. Natural history of gastroesophageal reflux disease and functional abdominal disorders. Am J Gastroenterol 2001;96:2905-14.
6. Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice. Am J Gastroenterol 2000;95:3176-83.
7. Crosland A, Jones R. Rectal bleeding: prevalence and consultation behaviour. Br Med J 1995;311:486-8.
8. Ford AC, Forman D, Bailey AG, et al. Irritable bowel syndrome: a 10-year natural history of symptoms, and factors that influence consultation behavior. Am J Gastroenterol 2008;103:1229-39.
9. Hillila MT, Farkkila MA. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Aliment Pharmacol Ther 2004;20:339-45.
10. Hungin APS, Whorwell PJ, Tack J, et al. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003;17:643-50.
11. Jones R, Lydeard S. Irritable bowel syndrome in the general population. Br Med J 1992;304:87-90.
12. Talley NJ, Jones M. Self-reported rectal bleeding in a United States community: prevalence, risk factors, and health care seeking. Am J Gastroenterol 1998;93:2179-83.
13. Wilson S, Roberts L, Roalfe A, et al. Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract 2004;54:495-502.
14. NICE. Referral guidelines for suspected cancer in adults and children. www.nice.org.uk/nicemedia/pdf/CG027fullguideline.pdf (accessed 14 Aug 2008).
15. NICE. Guidance on cancer services. Improving outcomes in colorectal cancers. www.nice.org.uk/nicemedia/pdf/CSGCCfullguidance.pdf (accessed 14 Aug 2008).
16. Ahmed S, Leslie A, Thaha MA, et al. Lower gastrointestinal symptoms are not predictive of colorectal neoplasia in a faecal occult blood screen-positive population. Br J Surg 2005;92:478-81.
17. Bjerregaard NC, Tottrup A, Sorensen HT, et al. Diagnostic value of self-reported symptoms in Danish outpatients referred with symptoms consistent with colorectal cancer. Colorectal Dis 2007;9:443-51.
18. Selvachandran SN, Hodder RJ, Ballal MS, et al. Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study. Lancet 2002;360:278-83.
19. Thompson MR, Perera A, Senapati A, et al. Predictive value of common symptom combinations in diagnosing colorectal cancer. Br J Surg 2007;94:1260-5.
20. Haynes RB, Sackett DL, Guyatt GH, et al. Evaluating diagnostic tests. In: Clinical epidemiology: how to do clinical practice research. Philadelphia, PA: Lippincott, Williams, and Wilkins, 2006:273-322.
21. The Cochrane Collaboration. The Cochrane Methods Group on systematic review of screening and diagnostic tests: Recommended methods. Available at: http://www.Cochrane.org/docs/sadtdoc1.2007 (accessed 13 Aug 2008).
22. Deeks JJ. Systematic reviews of evaluations of diagnostic and screening tests. Br Med J 2001;323:157-62.
23. Scherer K, Bedlack RS, Simel DL. Does this patient have myasthenia gravis? JAMA 2005;293:1906-1914.
24. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
25. Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Br Med J 2003;327:557-60.
26. Bellentani S, Baldoni P, Petrella S, et al. A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room. Fam Pract 1990;7:307-12.
27. Morini S, Hassan C, Meucci G, et al. Diagnostic yield of open access colonoscopy according to appropriateness. Gastrointest Endosc 2001;54:175-9.
28. Berkowitz A, Kaplan M. Indications for colonoscopy. An analysis based on indications and diagnostic yield. S Afr Med J 1993;83:245-8.
29. Steine M, Stordahl A, Laerum F, et al. Referrals for double-contrast barium examination. Factors influencing the probability of finding polyps or cancer. Scand J Gastroenterol 1994;29:260-4.
30. Brewster NT, Grieve DC, Saunders JH. Double-contrast barium enema and flexible sigmoidoscopy for routine colonic investigation. Br J Surg 1994;81:445-7.
31. de Bosset V, Froehlich F, Rey JP, et al. Do explicit appropriateness criteria enhance the diagnostic yield of colonoscopy? Endoscopy 2002;34:360-8.
32. Tate JJT, Royle GT. Open access colonoscopy for suspected colonic neoplasia. Gut 1988;29:1322-5.
33. Brenna E, Skreden K, Waldum HL, et al. The benefit of colonoscopy. Scand J Gastroenterol 1990;25:81-8.
34. Panzuto F, Chiriatti A, Bevilacqua S, et al. Symptom-based approach to colorectal cancer: survey of primary care physicians in Italy. Dig Liver Dis 2003;35:869-75.
35. Cheong KL, Roohi S, Jarmin R, et al. The yield for colorectal cancer and adenoma by indication at colonoscopy. Med J Malaysia 2000;55:464-6.
36. Neugut AI, Garbowski GC, Waye JD, et al. Diagnostic yield of colorectal neoplasia with colonoscopy for abdominal pain, change in bowel habits, and rectal bleeding. Am J Gastroenterol 1993;88:1179-83.
37. Thompson MR, Heath I, Ellis BG, et al. Identifying and managing patients at low risk of bowel cancer in general practice. Br Med J 2003;327:263-5.